West Pharmaceutical
406 hedge funds and large institutions have $9.57B invested in West Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 143 increasing their positions, 134 reducing their positions, and 32 closing their positions.
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
100% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 32
12% more capital invested
Capital invested by funds: $8.52B → $9.57B (+$1.05B)
9% more funds holding
Funds holding: 374 → 406 (+32)
7% more repeat investments, than reductions
Existing positions increased: 143 | Existing positions reduced: 134
0.89% less ownership
Funds ownership: 92.4% → 91.52% (-0.89%)
85% less call options, than puts
Call options by funds: $7.21M | Put options by funds: $47.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$71.8M |
| 2 |
Brown Advisory
Baltimore,
Maryland
|
+$26.3M |
| 3 |
Morgan Stanley
New York
|
+$25.4M |
| 4 |
BlackRock
New York
|
+$24.6M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$24.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$118M |
| 2 |
UIM
USS Investment Management
London,
United Kingdom
|
-$76.2M |
| 3 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$39.7M |
| 4 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$29.5M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$22.3M |
WST Hedge Fund Activity: Q3 2019 in Review
406 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2019, worth a combined $9.57B — up 12% from $8.52B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new WST positions and 32 closed out — a net gain of 32 holders — while 143 added to existing stakes and 134 trimmed.
The largest buyer was Millennium Management, adding an estimated $71.8M. The largest seller was AllianceBernstein, cutting an estimated $118M.
- 406 institutional investors held West Pharmaceutical (WST) as of Q3 2019, up from 374 in Q2 2019.
- Funds reported $9.57B of West Pharmaceutical stock for Q3 2019, up 12% quarter-over-quarter.
- 64 funds opened new West Pharmaceutical positions in Q3 2019 and 32 closed out, a net change of +32 holders.
- The largest West Pharmaceutical buyer in Q3 2019 was Millennium Management, an estimated $71.8M added.
- The largest West Pharmaceutical seller in Q3 2019 was AllianceBernstein, an estimated $118M sold.
Based on aggregated 13F filings for Q3 2019.